1. Home
  2. BOXL vs PPBT Comparison

BOXL vs PPBT Comparison

Compare BOXL & PPBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Boxlight Corporation

BOXL

Boxlight Corporation

HOLD

Current Price

$4.90

Market Cap

3.1M

ML Signal

HOLD

Logo Purple Biotech Ltd.

PPBT

Purple Biotech Ltd.

HOLD

Current Price

$1.64

Market Cap

2.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BOXL
PPBT
Founded
1985
2010
Country
United States
Israel
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.1M
2.9M
IPO Year
2015
2014

Fundamental Metrics

Financial Performance
Metric
BOXL
PPBT
Price
$4.90
$1.64
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$30.00
AVG Volume (30 Days)
1.4M
134.7K
Earning Date
04-16-2026
05-20-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$25,743,612.00
N/A
Revenue This Year
$2.70
N/A
Revenue Next Year
$5.00
N/A
P/E Ratio
N/A
N/A
Revenue Growth
26.37
N/A
52 Week Low
$0.50
$0.41
52 Week High
$10.15
$5.18

Technical Indicators

Market Signals
Indicator
BOXL
PPBT
Relative Strength Index (RSI) 85.78 31.98
Support Level $0.91 $0.57
Resistance Level $8.42 $3.09
Average True Range (ATR) 0.72 0.16
MACD 0.33 0.05
Stochastic Oscillator 56.28 62.22

Price Performance

Historical Comparison
BOXL
PPBT

About BOXL Boxlight Corporation

Boxlight Corp is a technology company that develops, sells, and services interactive solutions predominantly for the education market but also for the corporate and government sectors. The company currently designs, produces, and distributes interactive technologies, including interactive and non-interactive flat panel displays, LED video walls, media players, classroom audio and campus communication, cameras, and other peripherals for the education market and non-interactive solutions, including flat-panels, LED video walls, and digital signage for the enterprise market. It has three reportable segments - Europe, Middle East and Africa (EMEA), and North and Central America (Americas). The majority of revenue is derived from the sale of education technology products in the EMEA segment.

About PPBT Purple Biotech Ltd.

Purple Biotech Ltd is a clinical-stage biotechnology company focused on the development and commercialization of pharmaceuticals. It currently have a preclinical tri-specific antibodies platform, CAPTN-3, with its therapeutic candidates, IM1240 and IM1305, and two other oncology therapeutic candidates that are in the clinical trial phase, CM24 and NT219, neither of which has been approved for marketing and are not being sold, marketed, or commercialized.

Share on Social Networks: